Indeed, although most skin problems related to PD-1/PD-L1-blocking agents are mild, those agents are reported to rarely induce severe irAE such as Stevens-Johnson syndrome and toxic epidermal necrolysis (12–16). The gene discussed is CD274; the disease is toxic epidermal necrolysis.